PGHH Q1 FY27 Results Analysis: PAT Plunges 34%, Margin Collapses 933 bps

Procter & Gamble Hygiene and Health Care Ltd reported Q1 FY27 numbers with revenue of Rs. 891.46 Cr (-4.86% YoY) and PAT growth of -34.25% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

PGHH reported a weak Q1 with revenue declining 4.86% YoY and EBITDA margin collapsing 933 bps to 19.08% due to severe commodity inflation. PAT fell 34% YoY, contradicting management's qualitative guidance of double-digit earnings growth. No near-term catalysts are evident, and the competitive position appears weakened.

Key Investment Insights

Key Positives

• Other expenses as a % of revenue remained stable at 22.82% vs 22.69% a year ago
• Effective tax rate improved to 25.56% from 27.44% a year ago
• No exceptional items or one-time charges in the quarter

Risk Factors

• Revenue declined 4.86% YoY to Rs.891.46 Cr, a weak start to FY27
• EBITDA margin collapsed 933 bps YoY to 19.08% due to surging material costs
• PAT declined 34.25% YoY to Rs.126.27 Cr, the steepest drop in recent quarters
• Gross material cost rose 12.7% YoY despite revenue decline, driven by commodity inflation
• Employee costs rose 12.4% YoY, adding to cost pressure
• Management's stated goal of 'sustaining double-digit earnings growth' appears off-track with a 34% PAT decline